Matches in Wikidata for { <http://www.wikidata.org/entity/Q61918213> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q61918213 description "assaig clínic" @default.
- Q61918213 description "clinical trial" @default.
- Q61918213 description "clinical trial" @default.
- Q61918213 description "clinical trial" @default.
- Q61918213 description "clinical trial" @default.
- Q61918213 description "ensaio clínico" @default.
- Q61918213 description "ensayo clínico" @default.
- Q61918213 description "ensayu clínicu" @default.
- Q61918213 description "essai clinique" @default.
- Q61918213 description "klinisch onderzoek" @default.
- Q61918213 description "клінічне випробування" @default.
- Q61918213 description "临床试验" @default.
- Q61918213 name "Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q61918213 type Item @default.
- Q61918213 label "Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q61918213 prefLabel "Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia" @default.
- Q61918213 P1050 Q61918213-5B4C3296-0851-45A4-93E4-BF391412A644 @default.
- Q61918213 P1132 Q61918213-D4592FD4-5F49-481B-80F7-0D8E30CBE111 @default.
- Q61918213 P1476 Q61918213-67A70FF8-C871-486D-BFF6-D53DD90491BB @default.
- Q61918213 P17 Q61918213-4FE267BA-6DD8-427C-B41D-6D1A2EA7A9CE @default.
- Q61918213 P1813 Q61918213-AB0B2638-7B91-47FF-A73E-83386E001D0D @default.
- Q61918213 P2899 Q61918213-4564CAC3-940A-4323-BA9F-BC37AF404E3E @default.
- Q61918213 P3098 Q61918213-DE0BCF7E-F2F9-412C-9845-E5B23D4D9920 @default.
- Q61918213 P31 Q61918213-BB18B99D-E0E5-4E4F-9565-83A3B5E129C6 @default.
- Q61918213 P4844 Q61918213-1AB47510-06EC-458E-B73B-CD236D87C030 @default.
- Q61918213 P4844 Q61918213-77FF22B1-2838-46EC-8E68-A26BADC40A6F @default.
- Q61918213 P4844 Q61918213-7B4EAADC-BAB5-450C-99C2-707BFD360FAF @default.
- Q61918213 P4844 Q61918213-A632FCAE-550F-45FC-8025-DA1C34130FD0 @default.
- Q61918213 P580 Q61918213-C9A5E48C-8AC1-4095-96BC-C37D971248A7 @default.
- Q61918213 P6099 Q61918213-116E5398-52B6-4BE0-A020-DEDF6C60E532 @default.
- Q61918213 P6153 Q61918213-69806F46-0223-4E64-BBB9-12AA3BC2F8F8 @default.
- Q61918213 P6153 Q61918213-7972C2D1-F706-4D05-99E4-3545DF98C8E6 @default.
- Q61918213 P6153 Q61918213-F30FB829-E885-42D4-8EE8-FC4E8AF54AC3 @default.
- Q61918213 P8005 Q61918213-7ECF4BA3-7014-4B55-8FCE-3B1A6D211089 @default.
- Q61918213 P8363 Q61918213-999A0479-4978-4749-B29E-FE7E3E9B3498 @default.
- Q61918213 P1050 Q29496 @default.
- Q61918213 P1132 "+47" @default.
- Q61918213 P1476 "FLAT: Fludarabine, Cytarabine and Topotecan in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia" @default.
- Q61918213 P17 Q29 @default.
- Q61918213 P1813 "FLAT" @default.
- Q61918213 P2899 "+18" @default.
- Q61918213 P3098 "NCT00488709" @default.
- Q61918213 P31 Q30612 @default.
- Q61918213 P4844 Q180983 @default.
- Q61918213 P4844 Q185916 @default.
- Q61918213 P4844 Q415107 @default.
- Q61918213 P4844 Q419953 @default.
- Q61918213 P580 "2003-05-01T00:00:00Z" @default.
- Q61918213 P6099 Q42825046 @default.
- Q61918213 P6153 Q17137104 @default.
- Q61918213 P6153 Q5902584 @default.
- Q61918213 P6153 Q64442949 @default.
- Q61918213 P8005 Q76651189 @default.
- Q61918213 P8363 Q78089383 @default.